EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluation of the Effects of Umbelliferone and Naringin on Inflammatory and Steroidogenic Markers Against Testicular Torsion/Detorsion Injury in Rats

Selina Aksak Karameşe, Mehmet Ezer, İsmet Bilger Erihan, Bengül Özdemir

Laboratuvar Hayvanları Bilimi ve Uygulamaları Dergisi · 2026

DOI: 10.62425/jlasp.1986064 ↗
AbstractBibliografische Angaben

Abstract

This study evaluated and compared the protective effects of umbelliferone and naringin, each administered at two dose levels (50 and 100 mg/kg), against torsion/detorsion (T/D)-induced testicular injury in a rat model. Forty-two adult male Sprague-Dawley rats were randomly allocated into seven groups (n=6 each): control, Sham, T/D, and T/D treated with umbelliferone (50 and 100 mg/kg) or naringin (50 and 100 mg/kg) for seven consecutive days after torsion. Left testicular torsion was induced (720°, 2 h ischemia) followed by a 7-day reperfusion. Testicular histology (H&E), NF-κB immunohistochemistry, and serum ELISA levels of TNF-α, IL-1β, IL-8, StAR, 3β-HSD, and 17β-HSD were assessed. T/D produced marked seminiferous tubule disorganization, degenerated spermatids, and increased NF-κB immunopositivity compared with controls. T/D also significantly elevated TNF-α, IL-1β, and IL-8 and suppressed StAR, 3β-HSD, and 17β-HSD levels relative to control. Both umbelliferone and naringin, at either dose, preserved seminiferous tubule structure, reduced NF-κB immunoreactivity, and significantly lowered all three pro-inflammatory cytokines compared with the T/D group. 17β-HSD levels were significantly restored by both compounds at both doses, with a parallel, though not statistically significant, trend toward restoration observed for 3β-HSD and StAR. Umbelliferone and naringin confer comparable, meaningful protection against T/D-induced testicular injury by attenuating NF-κB activation, pro-inflammatory cytokine release, and steroidogenic enzyme suppression, supporting their potential as protective agents against testicular ischemia-reperfusion injury.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →